Skip to main content

Books in Drug discovery

Elsevier's Drug Delivery collection is an indispensable resource for scientists and researchers in the pharmaceutical field, exploring the administration of pharmaceutical compounds for therapeutic effects from molecule identification to medication development. It provides comprehensive coverage, including crucial aspects such as drug screening, medicinal chemistry, and preclinical safety assessments.

41-50 of 69 results in All results

Cancer Drug Design and Discovery

  • 2nd Edition
  • September 30, 2013
  • Stephen Neidle
  • English
  • Hardback
    9 7 8 - 0 - 1 2 - 3 9 6 5 2 1 - 9
  • eBook
    9 7 8 - 0 - 1 2 - 3 9 7 2 2 8 - 6
Cancer Drug Design and Discovery, Second Edition is an important reference on the underlying principles for the design and subsequent development of new anticancer small molecule agents. New chapters have been added to this edition on areas of particular interest and therapeutic promise, including cancer genomics and personalized medicine, DNA-targeted agents and more. This book includes several sections on the basic and applied science of cancer drug discovery and features those drugs that are now approved for human use and are in the marketplace, as well as those that are still under development. By highlighting some of the general principles involved in taking molecules through basic science to clinical development, this book offers a complete and authoritative reference on the design and discovery of anticancer drugs for translational scientists and clinicians involved in cancer research.

The Future of Drug Discovery

  • 1st Edition
  • May 18, 2013
  • Tamas Bartfai + 1 more
  • English
  • Paperback
    9 7 8 - 0 - 1 2 - 4 0 7 1 8 0 - 3
  • eBook
    9 7 8 - 0 - 1 2 - 4 0 9 5 1 9 - 9
The Future of Drug Discovery: Who decides which diseases to treat? provides a timely and detailed look at the efforts of the pharmaceutical industry and how they relate, or should relate, to societal needs. The authors posit that as a result of increasing risk aversion and accelerated savings in research and development, the industry is not developing drugs for increasingly prevalent diseases, such as Alzheimer’s disease, untreatable pain, antibiotics and more. This book carefully exposes the gap between the medicines and therapies we need and the current business path. By analyzing the situation and discussing prospects for the next decade, the The Future of Drug Discovery is a timely book for all those who care about the development needs for drugs for disease.

Ligand Efficiency Indices for Drug Discovery

  • 1st Edition
  • January 22, 2013
  • Celerino Abad-Zapatero
  • English
  • Paperback
    9 7 8 - 0 - 1 2 - 4 0 4 6 3 5 - 1
  • eBook
    9 7 8 - 0 - 1 2 - 4 0 4 6 8 2 - 5
The purpose of Ligand Efficiency Indices for Drug Discovery: Towards an Atlas-Guided Paradigm is to introduce in a concise and self-contained form the concepts, ideas, applications and examples of efficiency-driven drug discovery to the biomedical community at large. The book emphasizes the use of 'new variables' and more objective numerical methods to drive drug discovery in an encompassing way. These 'new variables' are based on Ligand Efficiency Indices (LEIs) formulated in a way that permits mapping Chemico-Biological Space (CBS) in an Atlas-like representation. It provides a practical and timely discussion of the concepts, ideas, applications and examples of efficiency-driven drug discovery. This book emphasizes the use of a graphical representation and objective numerical methods to drive drug discovery more effectively. It presents the definition of LEIs and the corresponding efficiency planes within an atlas-like environment to provide a robust graphical and numerical framework for medicinal chemists and drug-discoverers.

Pharmacology in Drug Discovery

  • 1st Edition
  • September 1, 2011
  • Terry P. Kenakin
  • English
  • Paperback
    9 7 8 - 0 - 1 2 - 3 8 4 8 5 6 - 7
  • eBook
    9 7 8 - 0 - 1 2 - 3 8 4 8 5 7 - 4
Pharmacology in Drug Discovery: Understanding Drug Response is designed for all students, recent graduates, and new researchers in the pharmaceutical and biotechnology industries who need to interpret change in physiology induced by a chemical substance. Physiological systems customize chemical signal input to their own needs; therefore the same drug can have different effects in different physiological systems. The field of pharmacology is unique in that it furnishes the tools to analyze these different behaviors and traces them to their root cause. This enables predictions of drug behavior to be made in all systems, an invaluable tool for drug discovery because almost all drugs are developed in test systems far removed from the therapeutic one. This valuable resource provides simple explanations of the ways in which biological systems use basic biochemical mechanisms to produce fine chemical control of physiology, allowing for more informed predictions of drug effects in all systems and forming the basis of the drug-discovery process. Chapters follow a logical progression on how to characterize the pharmacology of any given molecule, and include important terminology, chapter summaries, references, and review questions to aid the reader in understanding and retention of the material.

Protein Structure and Diseases

  • 1st Edition
  • Volume 83
  • May 11, 2011
  • Rossen Donev
  • English
  • Hardback
    9 7 8 - 0 - 1 2 - 3 8 1 2 6 2 - 9
  • eBook
    9 7 8 - 0 - 1 2 - 3 8 1 2 6 3 - 6
Structural genomics is the systematic determination of 3D structures of proteins representative of the range of protein structure and function found in nature. The goal is to build a body of structural information that will predict the structure and potential function for almost any protein from knowledge of its coding sequence. This is essential information for understanding the functioning of the human proteome, the ensemble of tens of thousands of proteins specified by the human genome. While most structural biologists pursue structures of individual proteins or protein groups, specialists in structural genomics pursue structures of proteins on a genome wide scale. This implies large-scale cloning, expression and purification. One main advantage of this approach is economy of scale.

Progress in Medicinal Chemistry

  • 1st Edition
  • Volume 50
  • February 9, 2011
  • G. Lawton + 1 more
  • English
  • Hardback
    9 7 8 - 0 - 1 2 - 3 8 1 2 9 0 - 2
  • eBook
    9 7 8 - 0 - 1 2 - 3 8 1 2 9 1 - 9
Progress in Medicinal Chemistry provides a review of eclectic developments in medicinal chemistry. This volume continues in the serial's tradition of providing an insight into the skills required of the modern medicinal chemist; in particular, the use of an appropriate selection of the wide range of tools now available to solve key scientific problems.

Progress in Medicinal Chemistry

  • 1st Edition
  • Volume 49
  • October 6, 2010
  • G. Lawton + 1 more
  • English
  • Hardback
    9 7 8 - 0 - 1 2 - 3 8 1 2 9 2 - 6
  • eBook
    9 7 8 - 0 - 1 2 - 3 8 1 2 9 3 - 3
Progress in Medicinal Chemistry provides a review of eclectic developments in medicinal chemistry. This volume continues in the serial's tradition of providing an insight into the skills required of the modern medicinal chemist; in particular, the use of an appropriate selection of the wide range of tools now available to solve key scientific problems.

Membrane Proteins as Drug Targets

  • 1st Edition
  • Volume 91
  • August 24, 2010
  • Charles.A Lunn
  • English
  • Hardback
    9 7 8 - 0 - 1 2 - 3 8 1 2 8 8 - 9
  • eBook
    9 7 8 - 0 - 1 2 - 3 8 1 2 8 9 - 6
Membrane proteins continue to be prime drug targets because they perform essential processes in the cell including controlling the flow of information and materials between cells and mediating activities like hormone action and nerve impulses. The study of membrane proteins could lead to new and improved pharmaceutical treatments for a wide range of illnesses such as heart disease, cystic fibrosis and depression. Membrane Proteins as Drug Targets reviews the latest developments in the field.

Pharmacology

  • 1st Edition
  • June 19, 2009
  • Miles Hacker + 2 more
  • English
  • Hardback
    9 7 8 - 0 - 1 2 - 3 6 9 5 2 1 - 5
  • eBook
    9 7 8 - 0 - 0 8 - 0 9 1 9 2 2 - 5
Pharmacology meets the rapidly emerging needs of programs training pharmacologic scientists seeking careers in basic research and drug discovery rather than such applied fields as pharmacy and medicine. While the market is crowded with many clinical and therapeutic pharmacology textbooks, the field of pharmacology is booming with the prospects of discovering new drugs, and virtually no extant textbook meets this need at the student level. The market is so bereft of such approaches that many pharmaceutical companies will adopt Hacker et al. to help train new drug researchers. The boom in pharmacology is driven by the recent decryption of the human genome and enormous progress in controlling genes and synthesizing proteins, making new and even custom drug design possible. This book makes use of these discoveries in presenting its topics, moving logically from drug receptors to the target molecules drug researchers seek, covering such modern topics along the way as side effects, drug resistance, pharmacogenomics, and even nutriceuticals, one in a string of culminating chapters on the drug discovery process. The book is aimed at advanced undergraduates and beginning graduate students in medical, pharmacy, and graduate schools looking for a solid introduction to the basic science of pharmacology and envisioning careers in drug research.

Clinical and Translational Science

  • 1st Edition
  • December 15, 2008
  • David Robertson + 1 more
  • English
  • Paperback
    9 7 8 - 0 - 1 2 - 3 7 3 6 3 9 - 0
  • eBook
    9 7 8 - 0 - 0 8 - 0 9 2 0 1 9 - 1
Clinical or translational science is the field of study devoted to investigating human health and disease, interventions and outcomes for the purposes of developing new treatment approaches, devices, and modalities to improve health. New molecular tools and diagnostic technologies based on clinical and translational research have lead to a better understanding of human disease and the application of new therapeutics for enhanced health. Clinical and Translational Science is designed as the most authoritative and modern resource for the broad range of investigators in various medical specialties taking on the challenge of clinical research. Prepared with an international perspective, this resource begins with experimental design and investigative tools to set the scene for readers. It then moves on to human genetics and pharmacology with a focus on statistics, epidemiology, genomic information, drug discovery and development, and clinical trials. Finally, it turns to legal, social, and ethical issues of clinical research concluding with a discussion of future prospects to provide readers with a comprehensive view of the this developing area of science.